Verquvo 2.5 mg (Vericiguat)

Verquvo 2.5 mg contains Vericiguat, a prescription medication used to treat adults with chronic heart failure with reduced ejection fraction who have had a recent worsening event or hospitalization. It belongs to a class of drugs known as soluble guanylate cyclase (sGC) stimulators, which work by enhancing the nitric oxide signaling pathway. This leads to improved blood vessel function, reduced heart strain, and better blood flow throughout the body.

This medication is typically taken once daily with food, and its use can significantly lower the risk of cardiovascular death and hospitalization in eligible patients. The main benefits of Verquvo 2.5 mg include improved heart efficiency and reduced symptoms of heart failure, such as fatigue and shortness of breath. Like all medications, Verquvo may cause side effects. Common ones include hypotension (low blood pressure), anemia, and gastrointestinal discomfort. Patients should be monitored regularly for blood pressure and hemoglobin levels. Always take this medicine as prescribed and consult a healthcare provider for any concerns.